Literature DB >> 1905331

Autocrine stimulation of interleukin-1 alpha and transforming growth factor alpha production in human keratinocytes and its antagonism by glucocorticoids.

S W Lee1, V B Morhenn, M Ilnicka, E M Eugui, A C Allison.   

Abstract

Interleukin-1 (IL-1) and transforming growth factor alpha (TGF alpha) mRNA expression was analyzed in cultured normal human keratinocytes. Keratinocytes constititively express IL-1 mRNA when cultured in keratinocyte growth medium but not in Dulbecco's minimal essential medium containing fetal bovine serum, in which the cells differentiate. The predominant form of IL-1 expressed by keratinocytes is IL-1 alpha. Addition of IL-1 alpha to keratinocytes increased IL-1 alpha and TGF alpha mRNA expression in a dose-dependent manner. TGF alpha induced a similar increase in IL-1 alpha and TGF alpha mRNA in keratinocytes. Hydrocortisone decreased the expression of both IL-1 alpha and TGF alpha mRNA in keratinocytes. These findings document an autocrine mechanism by which IL-1 alpha and TGF alpha can stimulate the proliferation of keratinocytes in the skin. It is proposed that this autocrine loop may be hyperactive in psoriasis. Antagonism of the effects of this autocrine loop may be one of the mechanisms by which glucocorticoids exert clinically useful effects in psoriasis and other diseases of the skin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905331     DOI: 10.1111/1523-1747.ep12478503

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

1.  Synergistic epithelial responses to endotoxin and a naturally occurring muramyl peptide.

Authors:  T A Flak; L N Heiss; J T Engle; W E Goldman
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

Review 2.  Keratinocyte-derived tumor necrosis factor and the physiopathology of the skin.

Authors:  P F Piguet
Journal:  Springer Semin Immunopathol       Date:  1992

3.  Identification of an autocrine mechanism for regulating cell-cycle progression in murine keratinocytes.

Authors:  G M Curtin; S M Fischer; T J Slaga
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

4.  Growth of normal oral keratinocytes and squamous cell carcinoma cells in a novel protein-free defined medium.

Authors:  N Kamata; K Yokoyama; R Fujimoto; N Ueda; E Hayashi; H Nakanishi; M Nagayama
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

5.  In vitro cytotoxicity test for estimating non-ocular irritation dose of ophthalmic solutions.

Authors:  K Nagami; E Maki
Journal:  Cell Biol Toxicol       Date:  1993 Apr-Jun       Impact factor: 6.691

6.  EGFR and IL-1 signaling synergistically promote keratinocyte antimicrobial defenses in a differentiation-dependent manner.

Authors:  Andrew Johnston; Johann E Gudjonsson; Abhishek Aphale; Andrew M Guzman; Stefan W Stoll; James T Elder
Journal:  J Invest Dermatol       Date:  2010-10-21       Impact factor: 8.551

7.  Interleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells.

Authors:  C D Woodworth; E McMullin; M Iglesias; G D Plowman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

8.  Modulation of the IL-1 cytokine network in keratinocytes by intracellular IL-1 alpha and IL-1 receptor antagonist.

Authors:  W G Phillips; M Feldmann; S M Breathnach; F M Brennan
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

9.  UVB and proinflammatory cytokines synergistically activate TNF-alpha production in keratinocytes through enhanced gene transcription.

Authors:  Muhammad M Bashir; Meena R Sharma; Victoria P Werth
Journal:  J Invest Dermatol       Date:  2008-11-13       Impact factor: 8.551

Review 10.  The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier.

Authors:  Tom Macleod; Anna Berekmeri; Charlie Bridgewood; Martin Stacey; Dennis McGonagle; Miriam Wittmann
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.